JOURNAL ARTICLE
[Chronic cold agglutinin disease].
Tidsskrift for Den Norske Lægeforening : Tidsskrift for Praktisk Medicin, Ny Række 1995 Februrary 11
Chronic cold agglutinin disease is an uncommon form of haemolytic anaemia. Traditionally the "idiopatic" form and the "secondary" form (seen in some cases of malignant lymphoma) have been regarded as two clearly different entities. We describe three patients with chronic cold agglutinin disease in a population of 100,000. They had been previously diagnosed as having idiopatic autoimmune haemolytic anaemia, but further investigations revealed lymphoproliferative bone marrow disease in all three cases. We discuss some pathogenetic features of cold agglutinin disease on the basis of our observations and the available literature. In conclusion, this disease represents a spectrum of clonal lymphoproliferative disorders rather than separate primary and secondary forms. The therapeutic principles are discussed. Corticosteroids should usually not be used to treat this disease.
Full text links
Trending Papers
Fluid Resuscitation in Patients with Cirrhosis and Sepsis: A Multidisciplinary Perspective.Journal of Hepatology 2023 March 2
Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes.Cardiology Research 2023 Februrary
Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety.Curēus 2023 Februrary
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.Circulation 2023 March 17
What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).Journal of Clinical Medicine 2023 Februrary 27
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database of Systematic Reviews 2023 January 31
Long COVID: major findings, mechanisms and recommendations.Nature Reviews. Microbiology 2023 January 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app